Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor

Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor

US Patent 8652471 · Granted Feb 18, 2014

Estimated economic value: $19,406,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Factor VII (FVII(a))/TREM-like transcript 1 (TLT-1) bispecific antibodies2024
Bispecific antibodies2022
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (12022
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (12022
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (12022
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Factor VIII variants having a decreased cellular uptake2021
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Targeting tissue factor to activated platelets2018